How a 19th Century Law, Central to a National Telehealth Abortion Case, Could Impact Virginia
The order preserves nationwide telehealth access while Louisiana’s challenge to the Food and Drug Administration continues in lower courts.
- On Thursday, the Supreme Court temporarily preserved telehealth access to mifepristone, staying a lower court ruling that would have banned mail delivery while Louisiana's legal challenge against the Food and Drug Administration proceeds.
- Louisiana filed a lawsuit on May 1 in the 5th Circuit Court of Appeals against the FDA, Danco Laboratories, and GenBioPro, alleging that mail-delivery mifepristone resulted in illegal abortions and significant Medicaid costs.
- The American College of Obstetricians & Gynecologists joined 20 medical organizations in a Supreme Court amicus brief, with Dr. Camille A. Clare noting research proves mifepristone is safe and effective via telehealth.
- In his Supreme Court dissent, Justice Clarence Thomas cited the long-dormant 1873 Comstock Act, a law abortion opponents consider a potential vehicle for a national ban on mailing abortion-related items, including mifepristone.
- U.S. Rep. Jennifer McClellan is leading congressional efforts to repeal Comstock Act provisions while the FDA conducts a new safety review and legal challenges continue affecting mifepristone access nationwide.
16 Articles
16 Articles
How a 19th century law, central to a national telehealth abortion case, could impact Virginia
The Supreme Court temporarily preserved telehealth access to the abortion drug mifepristone Thursday until an appeals court can rule on a legal challenge to the medication the state of Louisiana filed against the U.S. Food and Drug Administration. The result…
Abortion pill mail ban would disproportionately harm Black, Hispanic women - Los Angeles Wave Newspaper Group
By Sunita Sohrabji Contributing Writer SAN FRANCISCO — Black and Hispanic women face the greatest risk of not being able to access abortion care if the Supreme Court upholds a lower court’s ban to end delivery of mifepristone —an abortion pill — by mail. If the Supreme Court does agree with the lower court’s ruling, mifepristone by mail would be banned across the U.S., even in states where abortion is legal. Currently, 25 states have passed laws…
SCOTUS upholds abortion pill telehealth access. And, Trump returns from China visit
The Supreme Court kept access to the abortion pill mifepristone available via telehealth. And, Trump says he made multiple trade deals during his state visit to China.
How a 19th-Century Law, Central to a National Telehealth Abortion Case, Could Impact Virginia
The Supreme Court temporarily preserved telehealth access to the abortion drug mifepristone on Thursday until an appeals court can rule on a legal challenge to the medication the state of Louisiana filed against the U.S. Food and Drug Administration. The result could have national implications by outlawing the mailing of Mifepristone — even in states without abortion bans, like Virginia. Continue reading How a 19th-Century Law, Central to a Nati…
How did SCOTUS rule on mifepristone telehealth?
Supreme Court keeps mifepristone access during litigation The U.S. Supreme Court ruled in a way that preserves access to mifepristone via telehealth for now, while related challenges continue in lower courts. In the latest phase of the abortion rights fight, several justices who would typically be…
Coverage Details
Bias Distribution
- 60% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium



